ipilimumab
bms
['melanoma']
tumor-infiltrating lymphocytes may represent a new treatment option for patients with advanced melanoma. #esmo22
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.